Optimal Duration of Antiplatelet Therapy Following Acute Coronary Syndrome
The Journal of Family Practice. 2017 December;66(12):
Funding for this newsletter series was provided by AstraZeneca.
December 18, 2017|Family Medicine
The Cardiovascular Insights for Primary Care Physicians eNewsletter Series summarizes key information and data on common cardiovascular issues facing primary care physicians today.
Optimal Duration of Antiplatelet Therapy Following Acute Coronary Syndrome is the fourth eNewsletter in this series.
